Dr. Joshua Randall Clevenger, MD

Dr. Clevenger practices at Summa Health System - Akron Campus in Akron, Ohio, part of General Catalyst.

Dr. Clevenger's NPI, 1386064962, was assigned on April 22, 2014. Dr. Clevenger graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2014. Dr. Clevenger holds Ohio license 35.139824.

Dr. Clevenger's primary practice is Summa Health System - Akron Campus, at 525 East Market Street, Akron, OH 44309 in Summit County. The practice phone is (330) 375-3000.

Dr. Clevenger's primary practice is Summa Health System - Akron Campus in Akron, Ohio, part of General Catalyst. Dr. Clevenger is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is Summa Health Medical Group. Dmand AI also links Dr. Clevenger to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clevenger practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Clevenger's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Clevenger is licensed in Ohio.

CMS data shows 1,200 Medicare services from Dr. Clevenger across 15 procedure codes in 2024, for 530 Medicare patients. Medicare paid $54,418 for them.

CMS counts 530 Medicare patients who saw Dr. Clevenger in 2024. The largest group is 65 to 74, with 236 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clevenger's median patient age at 72, with 49% women.

In 2024, Dr. Clevenger wrote 1,783 Medicare Part D claims for 335 patients. 83% of them were for generic drugs. CMS names the drug for 1,549 of them, across 25 drugs with 11 or more claims each, at $289,470 in total drug cost. In 2023, CMS named 793 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Clevenger for performance year 2024, reported through an alternative payment model (APM). Dr. Clevenger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Clevenger, published from 2017 to 2020. 2019 was the busiest year, with 2. The most frequent topics are Transcatheter Aortic Valve Replacement. Dr. Clevenger has published most often in J Invasive Cardiol. Dr. Clevenger's most frequent co-authors are Guilherme F. Attizzani, Marco A. Costa, MD and Alan H. Markowitz, MD.

CMS Open Payments shows 152 general payments to Dr. Clevenger from 26 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $410.

Dr. Clevenger graduated from Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University in 2014.